ERS International Congress, Milan 2017

---

ILDs: clinical problems

Thematic Poster
Chairs: M. Wijsenbeek (Rotterdam, Netherlands), S. Hart (Cottingham, United Kingdom), C. Albera (Orbassano (To), Italy), M. Funke-Chambour (Bern, Switzerland)

Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases d. eid (Egypt, Egypt)
Interstitial lung abnormalities in smokers are associated with increased mortality N. Hoyer (København S, Denmark)
Clinical significance of combined pulmonary fibrosis and emphysema H. Lee (Incheon, Republic of Korea)
Does enhanced respiratory support affect clinical outcomes in ILD Patients with acute Respiratory failure? A. Achaiah (Portsmouth, United Kingdom)
Correlation between lung sounds and HRCT signs of pulmonary fibrosis: a blinded prospective study. G. Sgalla (Modena, Italy)
Transbronchial biopsy adequacy and sample size in a multidisciplinary team approach to interstitial lung disease diagnosis: one-year Padova experience F. Lunardi (Padova, PD, Italy)
Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features M. Sterclova (Praha, Czech Republic)
Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years I. Strambu (Bucuresti 5, Romania)
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF) M. Bonini (London, United Kingdom)
Clubbing in patients with fibrotic interstitial lung diseases M. van Manen (Rotterdam, Netherlands)
Combined pulmonary fibrosis and emphysema (CPFE): How does cohabitation affect respiratory functions? F. Çiftci (Ankara, Turkey)
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location M. Sarasate Azkona (Barcelona, Spain)
Ultrasonographic features of typical HRCT signs of interstitial lung diseases A. Cui (Beijing, China)
EXHALED NITRIC OXIDE MEASUREMENTS IN PATIENTS WITH ACUTE-ONSET INTERSTITIAL LUNG DISEASE K. Oishi (Ube, Japan)
Spectrum of diffuse parenchymal lung diseases at a tertiary care center in India D. Behera (Chandigarh (U.T.), India)
The role of transbronchial biopsy (TBB) in the multidisciplinary diagnosis of interstitial lung disease (ILD) F. Fracasso (Isola Vicentina, Italy)
Hypoxic challange test (HCT) in patients with interstitial lund disease (ILD) M. Thirumaran (Wakefield, United Kingdom)
Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease P. Cameli (Certaldo, Italy)
Epidemiological profile of chronic interstitial lung diseases in Tunisian patients S. Aouadi (Ariana, Tunisia)
Bronchoalveolar lavage fluid protein concentrations define phenotipically distinct populations within group of patients with hypersensitivity pneumonitis (HP) P. Paluch (Praha, Czech Republic)